326 related articles for article (PubMed ID: 23723699)
1. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
Malhotra M; Tomaro-Duchesneau C; Prakash S
Biomaterials; 2013 Jan; 34(4):1270-80. PubMed ID: 23140978
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
[TBL] [Abstract][Full Text] [Related]
6. A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis.
Malhotra M; Lane C; Tomaro-Duchesneau C; Saha S; Prakash S
Int J Nanomedicine; 2011; 6():485-94. PubMed ID: 21562608
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.
Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A
Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597
[TBL] [Abstract][Full Text] [Related]
8. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
Rahmat D; Khan MI; Shahnaz G; Sakloetsakun D; Perera G; Bernkop-Schnürch A
Biomaterials; 2012 Mar; 33(7):2321-6. PubMed ID: 22169137
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
12. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
[TBL] [Abstract][Full Text] [Related]
13. Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.
Guţoaia A; Schuster L; Margutti S; Laufer S; Schlosshauer B; Krastev R; Stoll D; Hartmann H
Carbohydr Polym; 2016 Jun; 143():25-34. PubMed ID: 27083340
[TBL] [Abstract][Full Text] [Related]
14. Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.
Rondon EP; Benabdoun HA; Vallières F; Segalla Petrônio M; Tiera MJ; Benderdour M; Fernandes JC
Int J Nanomedicine; 2020; 15():6183-6200. PubMed ID: 32922001
[TBL] [Abstract][Full Text] [Related]
15. [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier].
Tian X; Wei F; Lin X; Feng W; Wang P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):486-90, 500. PubMed ID: 22826945
[TBL] [Abstract][Full Text] [Related]
16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
[TBL] [Abstract][Full Text] [Related]
18. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
Lu ZX; Liu LT; Qi XR
Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
[TBL] [Abstract][Full Text] [Related]
19. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]